This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Are Options Traders Betting on a Big Move in Trupanion Stock?
by Zacks Equity Research
Investors need to pay close attention to TRUP stock based on the movements in the options market lately.
Zacks Industry Outlook Highlights Aflac, Trupanion and Globe Life
by Zacks Equity Research
Zacks highlights Aflac, Trupanion, and Globe Life as key stocks in the accident & health insurance industry, which faces pricing pressure but benefits from tech adoption, underwriting strength, and growing demand.
3 Accident & Health Insurance Stocks to Watch Amid Pricing Pressure
by Tanuka De
Accident and Health Insurance stocks like AFL, TRUP and GL are set to gain from rising underwriting exposure and accelerated digitalization. However, pricing pressure is a concern given rising medical costs and inflation.
Here's What Key Metrics Tell Us About Trupanion (TRUP) Q2 Earnings
by Zacks Equity Research
Although the revenue and EPS for Trupanion (TRUP) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Trupanion (TRUP) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Trupanion (TRUP) delivered earnings and revenue surprises of +833.33% and +1.99%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Howard Hughes Holdings (HHH) Q2 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Howard Hughes Holdings (HHH) delivered earnings and revenue surprises of -56.44% and -12.21%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Aflac (AFL) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Aflac (AFL) delivered earnings and revenue surprises of +4.09% and +2.30%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Trupanion (TRUP) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Trupanion (TRUP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Employers Holdings (EIG) Q2 Earnings Lag Estimates
by Zacks Equity Research
Employers Holdings (EIG) delivered earnings and revenue surprises of -48.94% and +14.75%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
UNM Outperforms Industry, Trades at a Premium: Should You Buy the Stock?
by Zacks Equity Research
Unum Group outperforms in 2025 as core segments expand and the stock trades at a discount to the industry average.
Zacks Industry Outlook Highlights Aflac, Unum, Trupanion, Globe Life and AMERISAFE
by Zacks Equity Research
AFL, UNM, TRUP, GL and AMSF are poised to gain from rising exposure and tech adoption despite pricing pressure.
5 Accident & Health Insurance Stocks to Watch as Exposure Increases
by Tanuka De
Accident & Health Insurers AFL, UNM, TRUP, GL and AMSF are set to gain from rising underwriting exposure, despite ongoing pricing pressure.
Trupanion (TRUP) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Trupanion (TRUP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Wall Street Analysts Believe Trupanion (TRUP) Could Rally 50.25%: Here's is How to Trade
by Zacks Equity Research
The mean of analysts' price targets for Trupanion (TRUP) points to a 50.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Trupanion (TRUP) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Trupanion (TRUP) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Trupanion (TRUP) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Trupanion (TRUP) delivered earnings and revenue surprises of 25% and 1.17%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Aflac (AFL) Misses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Aflac (AFL) delivered earnings and revenue surprises of -1.19% and 1.26%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Will Lower General Insurance Profit Affect AIG's Q1 Earnings?
by Zacks Equity Research
American International's first-quarter earnings are likely to have witnessed a higher combined ratio in General Insurance.
Amerisafe (AMSF) Q1 Earnings Top Estimates
by Zacks Equity Research
Amerisafe (AMSF) delivered earnings and revenue surprises of 1.69% and 1.41%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Aflac Gears Up for Q1 Earnings: Will AFL Quack or Crack?
by Zacks Equity Research
AFL's first-quarter earnings are likely to have benefited from growing total adjusted revenues in Aflac U.S.
Allstate to Report Q1 Earnings: Can Higher Premiums Save the Day?
by Zacks Equity Research
ALL's first-quarter earnings are likely to have benefited from growing underwriting income from the Auto brand.
Trupanion (TRUP) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Trupanion (TRUP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks Industry Outlook Highlights Aflac, Unum, Trupanion, Employers and AMERISAFE
by Zacks Equity Research
Aflac, Unum, Trupanion, Employers and AMERISAFE have been highlighted in this Industry Outlook article.
5 Stocks to Watch From Prospering Accident & Health Insurance Industry
by Tanuka De
Lower claims frequency, moderate pricing and the adoption of technology are likely to boost the performance of Zacks Accident and Health Insurance industry players like AFL, UNM, TRUP, EIG and AMSF.
After Plunging -26.69% in 4 Weeks, Here's Why the Trend Might Reverse for Trupanion (TRUP)
by Zacks Equity Research
Trupanion (TRUP) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.